Chan Henry Lee - 16 Jun 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role: SVP, General Counsel
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: ONC
Transactions as of: 16 Jun 2025
Net transactions value: -$112,463
Form type: 4
Filing time: 18 Jun 2025, 17:12:07 UTC
Previous filing: 12 Jun 2025
Next filing: 31 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lee Chan Henry	SVP, General Counsel	C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND	/s/ Qing Nian, as Attorney-in-Fact	18 Jun 2025	0001980648

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONC	American Depositary Shares	Sale	$112,463	-422	-100%	$266.50	0	16 Jun 2025	Direct	F1, F2
holding	ONC	Ordinary Shares						278,434	16 Jun 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share represents 13 Ordinary Shares.
F2	The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Content

Each American Depositary Share represents 13 Ordinary Shares.

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.